![](/img/cover-not-exists.png)
Clinical benefit of ixazomib plus lenalidomideâdexamethasone in myeloma patients with nonâcanonical NFâκB pathway activation
Dash, Ajeeta B., Zhang, Jacob, Shen, Lei, Li, Bin, Berg, Deborah, Lin, Jianchang, AvetâLoiseau, Hervé, Bahlis, Nizar J., Moreau, Philippe, Richardson, Paul G., Di Bacco, AlessandraJournal:
European Journal of Haematology
DOI:
10.1111/ejh.13435
Date:
April, 2020
File:
PDF, 12.54 MB
2020